The enhancement apoptosis of osteosarcoma mesenchymal stem cells co-cultivation with peripheral blood mononuclear cells sensitized by secretome and granulocyte macrophage colony-stimulating factor

The advanced, metastasis, and reccurent of osteosarcoma (OS) patients have a poor prognosis postaggresive surgery and chemotherapy. Peripheral blood mononuclear cells (PBMCs) as cell-based immunotherapy may successful in the OS treatment. To investigate the enhancement apoptosis of OS-mesenchymal st...

Full description

Bibliographic Details
Main Authors: Ferdiansyah Mahyudin, Hizbillah Yazid, Mouli Edward, Mohammad Hardian Basuki, Yunus Abdul Bari, Fedik Abdul Rantam
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Journal of Advanced Pharmaceutical Technology & Research
Subjects:
Online Access:http://www.japtr.org/article.asp?issn=2231-4040;year=2020;volume=11;issue=4;spage=213;epage=219;aulast=Mahyudin
id doaj-6148fb4fa3d847bbad50d316260a5dae
record_format Article
spelling doaj-6148fb4fa3d847bbad50d316260a5dae2020-11-25T03:34:13ZengWolters Kluwer Medknow PublicationsJournal of Advanced Pharmaceutical Technology & Research2231-40400976-20942020-01-0111421321910.4103/japtr.JAPTR_52_20The enhancement apoptosis of osteosarcoma mesenchymal stem cells co-cultivation with peripheral blood mononuclear cells sensitized by secretome and granulocyte macrophage colony-stimulating factorFerdiansyah MahyudinHizbillah YazidMouli EdwardMohammad Hardian BasukiYunus Abdul BariFedik Abdul RantamThe advanced, metastasis, and reccurent of osteosarcoma (OS) patients have a poor prognosis postaggresive surgery and chemotherapy. Peripheral blood mononuclear cells (PBMCs) as cell-based immunotherapy may successful in the OS treatment. To investigate the enhancement apoptosis of OS-mesenchymal stem cells (OS-MSCs) co-cultivated with PBMCs sensitized using the secretome and granulocyte macrophage colony-stimulating factor (GMCSF). This true experimental study with posttest only control group design and in vitro study. The sample was cultured OS-MSCs which confirmed by Cluster of Differentiation-133 using immunocytochemistry (ICC) and histopathology analysis. The sample divided into six groups accordingly: OS-MSC, OS-MSC + PMBC, OS-MSC + PMBC + Secretome, OS-MSC + PMBC + GMCSF, OS-MSC + PBMC + Secretome + GMCSF (n = 5/N = 30). The enhancement of OS-MSCs apoptosis was analyzed through Interleukin-2 (IL-2) level through the Enyzme-Linked Immunosorbent Assay examination, expression of Signal Transducers and Activators of Transcription (STAT)-3 and caspase-3 by ICC. One-way analysis of variance test and Tukey Honestly Significant Difference to analyze the difference between the groups (P < 0.05). The highest of IL-2 level was found in the PBMC + Secretome + GMCSF group. The highest expression of caspase-3 was found in OS-MSC + PBMC + Secretome + GMCSF group with significant different between groups (P < 0.05). There was insignificant difference of STAT-3 epxression and IL-2 level between groups (P > 0.05). The co-cultivation of OS-MSCs and PBMSCs activated using secretome and GMCSF has a great ability to enhance OS-MSCs apoptosis.http://www.japtr.org/article.asp?issn=2231-4040;year=2020;volume=11;issue=4;spage=213;epage=219;aulast=Mahyudingranulocyte macrophage colony stimulating factormesenchymal stem cellsosteosarcomaperipheral blood mononuclear cellssecretome
collection DOAJ
language English
format Article
sources DOAJ
author Ferdiansyah Mahyudin
Hizbillah Yazid
Mouli Edward
Mohammad Hardian Basuki
Yunus Abdul Bari
Fedik Abdul Rantam
spellingShingle Ferdiansyah Mahyudin
Hizbillah Yazid
Mouli Edward
Mohammad Hardian Basuki
Yunus Abdul Bari
Fedik Abdul Rantam
The enhancement apoptosis of osteosarcoma mesenchymal stem cells co-cultivation with peripheral blood mononuclear cells sensitized by secretome and granulocyte macrophage colony-stimulating factor
Journal of Advanced Pharmaceutical Technology & Research
granulocyte macrophage colony stimulating factor
mesenchymal stem cells
osteosarcoma
peripheral blood mononuclear cells
secretome
author_facet Ferdiansyah Mahyudin
Hizbillah Yazid
Mouli Edward
Mohammad Hardian Basuki
Yunus Abdul Bari
Fedik Abdul Rantam
author_sort Ferdiansyah Mahyudin
title The enhancement apoptosis of osteosarcoma mesenchymal stem cells co-cultivation with peripheral blood mononuclear cells sensitized by secretome and granulocyte macrophage colony-stimulating factor
title_short The enhancement apoptosis of osteosarcoma mesenchymal stem cells co-cultivation with peripheral blood mononuclear cells sensitized by secretome and granulocyte macrophage colony-stimulating factor
title_full The enhancement apoptosis of osteosarcoma mesenchymal stem cells co-cultivation with peripheral blood mononuclear cells sensitized by secretome and granulocyte macrophage colony-stimulating factor
title_fullStr The enhancement apoptosis of osteosarcoma mesenchymal stem cells co-cultivation with peripheral blood mononuclear cells sensitized by secretome and granulocyte macrophage colony-stimulating factor
title_full_unstemmed The enhancement apoptosis of osteosarcoma mesenchymal stem cells co-cultivation with peripheral blood mononuclear cells sensitized by secretome and granulocyte macrophage colony-stimulating factor
title_sort enhancement apoptosis of osteosarcoma mesenchymal stem cells co-cultivation with peripheral blood mononuclear cells sensitized by secretome and granulocyte macrophage colony-stimulating factor
publisher Wolters Kluwer Medknow Publications
series Journal of Advanced Pharmaceutical Technology & Research
issn 2231-4040
0976-2094
publishDate 2020-01-01
description The advanced, metastasis, and reccurent of osteosarcoma (OS) patients have a poor prognosis postaggresive surgery and chemotherapy. Peripheral blood mononuclear cells (PBMCs) as cell-based immunotherapy may successful in the OS treatment. To investigate the enhancement apoptosis of OS-mesenchymal stem cells (OS-MSCs) co-cultivated with PBMCs sensitized using the secretome and granulocyte macrophage colony-stimulating factor (GMCSF). This true experimental study with posttest only control group design and in vitro study. The sample was cultured OS-MSCs which confirmed by Cluster of Differentiation-133 using immunocytochemistry (ICC) and histopathology analysis. The sample divided into six groups accordingly: OS-MSC, OS-MSC + PMBC, OS-MSC + PMBC + Secretome, OS-MSC + PMBC + GMCSF, OS-MSC + PBMC + Secretome + GMCSF (n = 5/N = 30). The enhancement of OS-MSCs apoptosis was analyzed through Interleukin-2 (IL-2) level through the Enyzme-Linked Immunosorbent Assay examination, expression of Signal Transducers and Activators of Transcription (STAT)-3 and caspase-3 by ICC. One-way analysis of variance test and Tukey Honestly Significant Difference to analyze the difference between the groups (P < 0.05). The highest of IL-2 level was found in the PBMC + Secretome + GMCSF group. The highest expression of caspase-3 was found in OS-MSC + PBMC + Secretome + GMCSF group with significant different between groups (P < 0.05). There was insignificant difference of STAT-3 epxression and IL-2 level between groups (P > 0.05). The co-cultivation of OS-MSCs and PBMSCs activated using secretome and GMCSF has a great ability to enhance OS-MSCs apoptosis.
topic granulocyte macrophage colony stimulating factor
mesenchymal stem cells
osteosarcoma
peripheral blood mononuclear cells
secretome
url http://www.japtr.org/article.asp?issn=2231-4040;year=2020;volume=11;issue=4;spage=213;epage=219;aulast=Mahyudin
work_keys_str_mv AT ferdiansyahmahyudin theenhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor
AT hizbillahyazid theenhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor
AT mouliedward theenhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor
AT mohammadhardianbasuki theenhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor
AT yunusabdulbari theenhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor
AT fedikabdulrantam theenhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor
AT ferdiansyahmahyudin enhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor
AT hizbillahyazid enhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor
AT mouliedward enhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor
AT mohammadhardianbasuki enhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor
AT yunusabdulbari enhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor
AT fedikabdulrantam enhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor
_version_ 1724559866626834432